Disease activity measurement in rheumatoid arthritis - Why is a joint count abdicable;Krankheitsaktivitätsmessung bei der rheumatoiden arthritis - Warum können wir auf joint counts in der routine verzichten

Aktuelle Rheumatologie

Volumn 34, Issue 3, 2009, Pages 167-170

  Rintelen, Bernhard ^a,b   Leeb, B F ^a,b  

^a II Medizinische Abteilung   (Austria)

^b Karl Landsteiner Institut für Klinische Rheumatologie   (Austria)

Author keywords

DAS28; Disease activity; RADAI 5; Rheumatoide arthritis

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28; HUMAN; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX; ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3; SCORING SYSTEM; SIMPLIFIED DISEASE ACTIVITY INDEX;

EID: 67650862806     PISSN: 0341051X     EISSN: 14389940     Source Type: Journal    
DOI: 10.1055/s-0029-1225345     Document Type: Review

References (33)

1. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classifi cation of rheumatoid arthritis. Arthritis Rheum 1988 ; 31 : 315-324
2. Grigor C, Capell H, Stirling A et al. Eff ect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a singleblind randomised controlled trial. Lancet 2004 ; 364 (9430) : 263-269
3. Pincus T, Segurado OG. Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis 2006 ; 65 (6) : 820-822
4. Hart LE, Tugwell P, Buchanan WW et al. Grading of tenderness as a source of interrater error in the Ritchie articular index . J Rheumatol 1985 ; 12 (4) : 716-717
5. Klinkhoff AV, Bellamy N, Bombardier C et al. An experiment in reducing interobserver variability of the examination for joint tenderness. J Rheumatol 1988 ; 15 : 492-494
6. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defi ning disease status in ankylosing spondylitis: the development of the bath ankylosing spondylitis disease activity index. J Rheumatol 1994 ; 21 : 2286-2291
7. Fries JF, Spitz P, Kraines RG et al. Measurements of patient outcomes in arthritis. Arthritis Rheum 1980 ; 23 : 137-145
8. Wolfe F, Michaud K, Gefeller O et al. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003 ; 48 (6) : 1530-1542
9. Prevoo ML, van' t Hof MA, Kuper HH et al. Modifi ed disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995 ; 38 : 44-48
10. Smolen JS, Breedveld FC, Schiff MH et al. A simplifi ed disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003 ; 42 : 244-257
11. Aletaha D, Nell VP, Stamm T et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005 ; 7 (4) : R796-R806
12. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology: preliminary defi nition of improvement in rheumatoid arthritis. Arthritis Rheum 1995 ; 38 : 727-735
13. Yazici Y, Bergman M, Pincus T. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores. J Rheumatol 2008 ; 35 : 603-609
14. Rintelen B, Sautner J, Haindl PM et al. Comparison of Three Rheumatoid Arthritis Disease Activity Scores in Clinical Routine. Scand J Rheumatol 2009, [in press]
15. Stucki G, Liang MH, Stucki S et al. A self-administered Rheumatoid Arthritis Disease Activity Index (RADAI) for epidemiologic research: psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995 ; 38 : 795-798
16. Fransen J, Langenegger T, Michel BA et al. Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology 2000 ; 39 : 321-327
17. Leeb BF, Haindl PM, Maktari A et al. Patient-Centered Rheumatoid Arthritis Disease Activity Assessment By A Modifi ed RADAI. J Rheumatol 2008 ; 35 : 1294-1299
18. Rintelen B, Haindl PM, Sautner J et al. The RADAI-5 in daily use. Proposal for Disease Activity Categories. J Rheumatol 2009, [Epub ahead of print]
19. Pincus T, Swearingen CJ, Bergman N et al. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol 2008 ; 35 : 2136-2147
20. Pincus T, Bergman MJ, Yazici Y et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physicianreported measures. Rheumatology 2008 ; 47 : 345-349
21. Puolakka K, Kautiainen H, Möttö nen T et al. FIN-RACo Trial Troup. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Ann Rheum Dis 2005 ; 64 : 130-133
22. Dougados M, Schmidely N, Le Bars M et al. Evaluation of diff erent methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data. Ann Rheum Dis published online 11 Dec 2008
23. Fransen J, Häuselmann H, Michel BA et al. Responsiveness of the selfassessed rheumatoid arthritis disease activity index to a fl are of disease activity. Arthritis Rheum 2001 ; 44 : 53-60
24. Leeb BF, Haindl PM, Maktari A et al. Disease Activity Score-28 Values Diff er Considerably Depending on Patient ' s Pain Perception and Sex. J Rheumatol 2007 ; 34 : 2382-2387
25. Rintelen B, Haindl PM, Nothnagl T et al. SDAI/CDAI-Levels in Rheumatoid Arthritis Patients are Highly Determined by Patient ' s Pain Perception and Gender. Scand J Rheumatol 2008 ; 29 : 1-4
26. Pincus T, Amara I, Seguardo OG et al. Relative effi ciencies of physician/ assessor global estimates and patient questionnaire measures are similiar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials. J Rheumatol 2008 ; 35 : 201-205
27. Pincus T. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis. Bull NYU Hosp Jt Dis 2008 ; 66 : 216-223
28. Wolfe F, Pincus T, Thompson AK et al. The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice. Arthritis Rheum 2003 ; 49 : 59-63
29. Hetland ML, Stengaard-Pedersen K, Junker P et al. CIMESTRA Study Group. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel- group, placebo-controlled study. Arthritis Rheum 2006 ; 54 : 1401-1409
30. Wakefi eld RJ, Green MJ, Marzo-Ortega H et al. Should oligoarthritis be reclassifi ed? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 2004 ; 63 : 382-385
31. Kane D, Balint PV, Sturrock RD. Ultrasonography is superior to clinical examination in the detection and localization of knee joint eff usion in rheumatoid arthritis. J Rheumatol 2003 ; 30 : 966-971
32. Criswell LA, Such CL, Neuhaus JM et al. Variation among rheumatologists in clinical outcomes and frequency of offi ce visits for rheumatoid arthritis. J Rheumatol 1997 ; 24 : 1266-1271
33. Pincus T, Sokka T. Quantitative Clinical Assessment in Busy Rheumatological Settings: the Value of Short Patient Questionnaires. J Rheumatol 2008 ; 35 : 1235-1237